By a News Reporter-Staff News Editor at Investment Weekly News -- Envision Healthcare Holdings, Inc. (NYSE: EVHC) (the "Company") announced the pricing of a secondary offering of 27.5 million shares of its common stock by certain stockholders of the Company at a public offering price of $34.00 per share. Investment funds sponsored by, or affiliated with, Clayton, Dubilier & Rice, LLC ("CD&R") and certain executive officers, directors and employees of the Company will be the selling stockholders. In connection with the offering, the CD&R investment funds have granted the underwriters an option to purchase up to 4.125 million additional shares of common stock. The Company will not receive any proceeds from the secondary offering. The secondary offering will be made only by means of a prospectus.
Goldman, Sachs & Co., Barclays, BofA Merrill Lynch and Citigroup are serving as lead joint book-running managers and as representatives of the underwriters for the secondary offering.
When available, copies of the final prospectus relating to the secondary offering may be obtained from Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, New York 10282, or by telephone at 1-866-471-2526, or by facsimile at 1-212-902-9316 or by email at firstname.lastname@example.org; Barclays, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (888) 603-5847, or by e-mail at email@example.com; BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attn: Prospectus Department or by email at firstname.lastname@example.org; or Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (800) 831-9146, or by e-mail email@example.com.
Keywords for this news article include: Industry, Goldman Sachs, Banking and Finance, Financial Companies, Investment Companies, Investment and Finance, Financial Service Companies, Envision Healthcare Holdings Inc..
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC